ICLR|ICON PLC|Preço:150.590|Var. %:5.20

Mais detalhes de ICON PLC Empresa

ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.

Informações de ICON PLC



Código da empresaICLR

Nome da EmpresaICON PLC

Data de listagemMay 15, 1998

CEOBalfe (Barry Edward)

Número de funcionários41900

Tipo de títulosOrdinary Share

Fim do ano fiscalMay 15

EndereçoSouth County Business Park

CidadeDUBLIN

Bolsa de valoresNASDAQ OMX - NASDAQ BASIC

PaísIreland

Código postal- -

Telefone35312912000

Sitehttps://www.iconplc.com/

Código da empresaICLR

Data de listagemMay 15, 1998

CEOBalfe (Barry Edward)

Executivos da empresa ICON PLC



Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Ciaran Murray

Non-Executive Independent Chairman of the Board

20.00K

+657.00%

Dr. John Climax

Independent Director

--

Mr. Diarmaid Cunningham

Chief Administrative Officer, General Counsel, Company Secretary

--

Dr. Stephen (Steve) Cutler, Ph.D.

Non-Executive Director

--

Mr. Eugene Mccague

Independent Director

--

Ms. Julie O'Neill

Independent Director

--

Mr. Ronan Murphy

Lead Independent Director

--

Dr. Linda S. Grais, M.D., J.D.

Independent Director

--

Ms. Anne C. Whitaker

Independent Director

--

Mr. Barry Edward Balfe

Chief Executive Officer, Chief Operating Officer

--

Ver Mais

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Ciaran Murray

Non-Executive Independent Chairman of the Board

20.00K

+657.00%

Dr. John Climax

Independent Director

--

Mr. Diarmaid Cunningham

Chief Administrative Officer, General Counsel, Company Secretary

--

Dr. Stephen (Steve) Cutler, Ph.D.

Non-Executive Director

--

Mr. Eugene Mccague

Independent Director

--

Ms. Julie O'Neill

Independent Director

--

Detalhamento da receita

Moeda: USDAtualizado em: ter, 6 de jan

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

Os dados relevantes ainda não foram divulgados pela empresa.

Por RegiãoUSD

Nome

Receita

Proporção

Ireland

758.53M

37.13%

United States

647.28M

31.69%

Rest of Europe

402.44M

19.70%

Rest of the World

234.57M

11.48%

Por Empresa

Por Região

Os dados relevantes ainda não foram divulgados pela empresa.

Distribuição de ações

Atualizado em: sáb, 20 de dez

Investidores

Tipos de investidores

Investidores

Proporção

Artisan Partners Limited Partnership

9.26%

Wellington Management Company, LLP

6.07%

Orbis Investment Management Ltd.

5.42%

Principal Global Investors (Equity)

3.93%

Ninety One UK Limited

3.86%

Outro

71.46%

Investidores

Proporção

Artisan Partners Limited Partnership

9.26%

Wellington Management Company, LLP

6.07%

Orbis Investment Management Ltd.

5.42%

Principal Global Investors (Equity)

3.93%

Ninety One UK Limited

3.86%

Outro

71.46%

Tipos de investidores

Investidores

Proporção

Investment Advisor/Hedge Fund

48.93%

Investment Advisor

41.94%

Hedge Fund

8.84%

Pension Fund

2.41%

Research Firm

2.03%

Sovereign Wealth Fund

1.43%

Bank and Trust

1.13%

Family Office

1.09%

Family Office

1.09%

Participação acionária institucional



Atualizado em: qui, 1 de jan

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2025Q4

1379

81.22M

106.37%

-16.19M

2025Q3

1350

79.42M

104.00%

-10.34M

2025Q2

1335

74.28M

95.51%

-11.33M

2025Q1

1362

81.04M

101.97%

-5.18M

2024Q4

1334

80.88M

97.97%

-5.29M

2024Q3

1290

83.28M

100.86%

-2.02M

2024Q2

1273

83.12M

100.37%

-2.47M

2024Q1

1254

83.08M

100.49%

-3.81M

2023Q4

1237

84.94M

102.98%

-3.00M

2023Q3

1213

86.31M

104.85%

-1.65M

Ver Mais

Atividade dos acionistas



Nome

Ações detidas

Proporção

Variação

Var. %

Data

Artisan Partners Limited Partnership

7.07M

9.26%

-113.51K

-1.58%

Sep 30, 2025

Wellington Management Company, LLP

4.64M

6.07%

+975.27K

+26.63%

Sep 30, 2025

Orbis Investment Management Ltd.

4.14M

5.42%

+3.80M

+1132.98%

Sep 30, 2025

Principal Global Investors (Equity)

3.28M

4.29%

+2.89M

+739.17%

Sep 30, 2025

Ninety One UK Limited

3.01M

3.94%

+12.49K

+0.42%

Sep 30, 2025

Invesco Advisers, Inc.

2.85M

3.73%

+321.71K

+12.73%

Sep 30, 2025

Harris Associates L.P.

2.34M

3.07%

+704.50K

+43.01%

Sep 30, 2025

MFS Investment Management

3.18M

4.17%

-240.69K

-7.03%

Sep 30, 2025

Templeton Investment Counsel, L.L.C.

2.08M

2.72%

+390.29K

+23.14%

Sep 30, 2025

Ruane, Cunniff & Goldfarb L.P.

1.70M

2.23%

-7.19K

-0.42%

Sep 30, 2025

Ver Mais

ETFs Relacionados



Atualizado em: sáb, 6 de dez

Nome

Proporção

iShares MSCI Ireland ETF

4.48%

Harbor Health Care ETF

3.34%

Polen Capital International Growth ETF

3.14%

VanEck Biotech ETF

3.13%

Motley Fool Global Opportunities ETF

2.94%

Tema Durable Quality ETF

2.07%

Invesco Bloomberg Pricing Power ETF

1.89%

Running Oak Efficient Growth ETF

1.83%

FPA Global Equity ETF

1.81%

Brandes US Value ETF

1.77%

Ver Mais

iShares MSCI Ireland ETF

Proporção4.48%

Harbor Health Care ETF

Proporção3.34%

Polen Capital International Growth ETF

Proporção3.14%

VanEck Biotech ETF

Proporção3.13%

Motley Fool Global Opportunities ETF

Proporção2.94%

Tema Durable Quality ETF

Proporção2.07%

Invesco Bloomberg Pricing Power ETF

Proporção1.89%

Running Oak Efficient Growth ETF

Proporção1.83%

FPA Global Equity ETF

Proporção1.81%

Brandes US Value ETF

Proporção1.77%

Dividendo



Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Sem dados

Desdobramento de ações



Data

Data ex-dividendo

Tipo

Proporção

Sem dados

Data

Data ex-dividendo

Tipo

Proporção

Sem dados